- About Us
- Contact
- Editorial Staff
- Editorial Boards
- Advertise
- Do Not Sell My Information
- Terms & Conditions
- Privacy Policy
© 2022 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.
Sean D. Sullivan, PhD
Articles
Impact of a Value-Based Formulary in Three Chronic Disease Cohorts
March 27, 2017
Article
A value-based formulary was implemented that used cost-effectiveness analysis to inform medication co-payments. Diabetes cohort expenditures decreased by $9 per member per month.
Private Sector Risk-Sharing Agreements in the United States: Trends, Barriers, and Prospects
September 15, 2015
Article
Assessment of current trends, success factors, and challenges in the use of risk-sharing agreements in the US private sector.
Increasing Pharmaceutical Copayments: Impact on Asthma Medication Utilization and Outcomes
October 11, 2011
Article
Even small changes in average copayment for long-term controller asthma medications can result in significant reductions in medication use and increases in healthcare services.
Colony-Stimulating Factor Prescribing Patterns in Patients Receiving Chemotherapy for Cancer
September 21, 2010
Article
We linked health insurance records to cancer registry data to analyze colony-stimulating factor use, finding wide divergence from that recommended by practice guidelines.